2020-05-28 16:34 Creative Biolabs has established a platform to predict and assess a series of post-translational modifications of antibody therapeutics. Deamidation of asparagine residues is one of the most common post-translational modifications occurring in therapeutic proteins produced using recombinant DNA technology, resulting in the conversion of an asparagine residue to a mixture of isoaspartate and aspartate.
Вы можете показать это желание на своем сайте, в блоге, в форуме и т.д., скопировав и вставив туда этот HTML-код.
